Thermo Fisher Scientific (TMO) Research & Development (2009 - 2026)

Thermo Fisher Scientific has reported Research & Development for 18 years, with the latest figure at $364.0 million in Q2 2026.

• Research & Development for Q2 2026 came in at $364.0 million, up 3.41% year-over-year; the trailing twelve-month figure through Jun 2026 was $1.4 billion (down 0.85% YoY), and the FY2025 annual result was $1.4 billion, up 0.5% from the prior year.
• Research & Development climbed to $364.0 million in Q2 2026, from $336.0 million in the prior quarter.
• Over five years, Research & Development peaked at $391.0 million in Q4 2022 and troughed at $319.0 million in Q3 2023.
• A 5-year average of $349.7 million and a median of $346.0 million in 2023 frame the typical range for Research & Development.
• The widest annual swing landed in 2023, when Research & Development fell 16.37%; it then advanced 14.37% in 2024.
• A 5-year view of Research & Development shows it stood at $391.0 million in 2022, then fell by 16.37% to $327.0 million in 2023, then advanced by 14.37% to $374.0 million in 2024, then retreated by 4.81% to $356.0 million in 2025, then grew by 2.25% to $364.0 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $364.0 million in Q2 2026, $336.0 million in Q1 2026, and $356.0 million in Q4 2025.